The STX11 Gene Hemophagocytic Lymphohistiocytosis Type 4 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the STX11 gene, which are linked to the development of Hemophagocytic Lymphohistiocytosis (HLH) type 4. HLH is a rare but severe immune system disorder characterized by excessive inflammation and tissue damage, primarily affecting infants and young children. Type 4 HLH, associated with mutations in the STX11 gene, involves symptoms like fever, splenomegaly, cytopenias, and hyperferritinemia. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic abnormalities in the STX11 gene, offering crucial information for the diagnosis, treatment planning, and genetic counseling for affected families. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, playing a pivotal role in the management and understanding of this life-threatening condition.
The STXBP2 gene plays a crucial role in the immune system's function, specifically in the regulation of cellular vesicle trafficking. Mutations in this gene are associated with Hemophagocytic Lymphohistiocytosis type 5 (HLH-5), a rare but severe immune disorder. This condition is characterized by the body's immune system attacking its own tissues and organs, leading to a host of symptoms including fever, enlarged liver or spleen, and a decreased number of blood cells.
The genetic test for STXBP2 gene mutations is a critical tool in diagnosing HLH-5. It involves analyzing the patient's DNA to identify any mutations in the STXBP2 gene that could lead to the condition. Early diagnosis through this genetic testing can be pivotal in managing the disease's progression and improving the patient's quality of life.
In the UAE, this specific genetic test is available at DNA Labs UAE, a facility known for its comprehensive genetic testing services. The cost of the STXBP2 gene test is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the subsequent laboratory analysis to detect any genetic abnormalities associated with HLH-5.
Given the complexity and the need for specialized analysis, the test's cost reflects the intricate processes and the expertise required to accurately diagnose this condition. For patients suspected of having HLH-5 or those with a family history of the disorder, this genetic test provides a crucial step towards a definitive diagnosis and the formulation of an appropriate treatment plan.
The CCBE1 gene Hennekam lymphangiectasia-lymphedema syndrome type 1 genetic test is a specialized diagnostic procedure designed to identify mutations in the CCBE1 gene, which are linked to Hennekam syndrome. This condition is characterized by lymphangiectasia (dilation of the lymphatic vessels), lymphedema (swelling due to lymphatic fluid), and other developmental anomalies affecting the face, skin, and limbs. Early and accurate diagnosis through this genetic test enables targeted management and therapy, significantly improving the quality of life for affected individuals.
The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high standards of accuracy and reliability. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. For families and individuals facing symptoms or with a history suggestive of Hennekam syndrome, this test offers a critical resource for confirmation of the diagnosis and subsequent planning for treatment and management.
The SP110 Gene Hepatic Veno-occlusive Disease with Immunodeficiency Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SP110 gene. These mutations are associated with Hepatic Veno-occlusive Disease with Immunodeficiency (VODI), a rare and potentially life-threatening condition characterized by liver damage and significant immune system defects. The test plays a critical role in the early diagnosis and management of the condition, enabling healthcare providers to tailor specific treatment plans for affected individuals.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory to detect any genetic anomalies in the SP110 gene. Early detection through this genetic test is vital, as it can significantly influence the course of treatment and improve the prognosis for individuals with VODI. DNA Labs UAE employs state-of-the-art technology and adheres to strict quality control measures, ensuring accurate and reliable test results for patients and their families.
The TLR3 Gene Herpes Simplex Encephalitis Type 2 Susceptibility Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE. This test is specifically designed to evaluate an individual's genetic susceptibility to Herpes Simplex Encephalitis (HSE) Type 2, a severe and potentially life-threatening condition caused by the Herpes Simplex Virus (HSV). The focus of this test is on the TLR3 gene, which plays a crucial role in the body's immune response to viral infections, including HSV. Mutations or variations in the TLR3 gene can significantly affect how an individual's immune system responds to HSV, thereby influencing their susceptibility to developing HSE.
The test involves a comprehensive analysis of the TLR3 gene to identify any genetic variations that may increase the risk of HSE Type 2. This information is vital for individuals with a family history of HSE or those who have experienced severe viral infections, as it can guide personalized medical and preventive strategies to mitigate the risk of developing HSE.
The cost of the TLR3 Gene Herpes Simplex Encephalitis Type 2 Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the genetic analysis and a detailed report, which provides insights into the patient's genetic predisposition to HSE Type 2. The test is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of the results. Individuals interested in this test are encouraged to consult with their healthcare provider to understand its implications and how it fits into their overall health management plan.
The SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SLC29A3 gene, which are associated with a rare disorder known as histiocytosis-lymphadenopathy plus syndrome. This condition is characterized by a wide range of symptoms, including, but not limited to, histiocytosis, lymph node enlargement, and potentially other systemic symptoms depending on the individual. The syndrome falls under the umbrella of histiocytic disorders, which involve an abnormal increase of histiocytes, a type of white blood cell, leading to tissue damage and organ dysfunction.
The test is performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. By analyzing a patient's DNA, the test can confirm the presence of mutations in the SLC29A3 gene, providing crucial information for the diagnosis, treatment planning, and management of the condition. This genetic insight not only helps in understanding the patient's condition better but also assists in predicting the disease course and potential response to treatment.
The cost of the SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome genetic test at DNA Labs UAE is 4400 AED. This investment is valuable for patients seeking a definitive diagnosis for their symptoms, which can often be complex and challenging to understand without a genetic basis. Early and accurate diagnosis through such genetic testing can significantly impact the quality of life and health outcomes for individuals with this rare syndrome.
The ANTXR2 Gene Hyaline Fibromatosis Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ANTXR2 gene, which are responsible for Hyaline Fibromatosis Syndrome (HFS). HFS is a rare genetic disorder characterized by the accumulation of hyaline, a clear substance, in the skin and various organs, leading to a range of symptoms including skin lesions, joint deformities, and in severe cases, fatal organ dysfunction. The test plays a crucial role in the early detection and management of the syndrome, allowing for appropriate interventions and genetic counseling for affected families. Priced at 4400 AED, this test is a valuable tool for those with a family history of HFS or exhibiting symptoms related to the condition, providing them with crucial insights into their genetic health and the possibility of passing the condition onto their offspring.
The STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the STAT3 gene, which are linked to Hyper-IgE Syndrome (HIES). This condition, also known as Job's Syndrome, is a rare immune disorder characterized by high levels of immunoglobulin E (IgE), eczema, and recurrent skin and lung infections. The test plays a crucial role in the accurate diagnosis and management of HIES, enabling targeted treatment strategies and improved patient care.
Performed using a sample of the patient's blood or saliva, the test involves advanced genetic sequencing techniques to scrutinize the STAT3 gene for specific mutations. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the genetic basis of the patient's condition. By identifying STAT3 gene mutations, healthcare providers can confirm a diagnosis of Hyper-IgE Syndrome, assess the risk of passing the condition to offspring, and tailor treatment plans to address the unique needs of each patient.
DNA Labs UAE is known for its state-of-the-art facilities and expert team of geneticists and medical professionals, ensuring high accuracy and reliability of test results. The STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test is a testament to the lab's commitment to offering advanced genetic testing services to diagnose and manage a wide range of genetic disorders effectively.
The "DOCK8 Gene Hyper-IgE Recurrent Infection Syndrome Autosomal Recessive Genetic Test" is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the DOCK8 gene. This gene is crucial for the proper functioning of the immune system, and mutations in DOCK8 can lead to Hyper-IgE Syndrome (HIES), a rare, primary immunodeficiency disorder. Individuals with HIES are characterized by high levels of immunoglobulin E (IgE), recurrent skin abscesses, pneumonia, and a propensity for autoimmune complications. The condition is autosomal recessive, meaning that two copies of the defective gene, one from each parent, are required for a child to be affected.
The test is particularly important for early diagnosis and management of the syndrome, helping to tailor appropriate treatment strategies and improve patient outcomes. Conducted at DNA Labs UAE, a leading facility for genetic and molecular diagnostics, the test ensures high accuracy and reliability. The cost for this comprehensive genetic test is 4400 AED, reflecting the sophisticated technology and expertise involved in identifying the specific mutations of the DOCK8 gene. By opting for this test, patients and their families can gain crucial insights into their genetic status regarding Hyper-IgE Syndrome, facilitating informed decisions about healthcare and management of the condition.
The HPGD Gene Hypertrophic Osteoarthropathy Type 1 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE. This test is designed to identify mutations in the HPGD gene, which are known to cause Hypertrophic Osteoarthropathy Type 1 (HOA1), a rare genetic disorder. HOA1 is characterized by abnormal bone growth, joint pain, and digital clubbing. The identification of a mutation in the HPGD gene can provide conclusive evidence for the diagnosis of HOA1, enabling healthcare providers to tailor treatment plans to the specific needs of the patient.
Priced at 4400 AED, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory. DNA Labs UAE employs state-of-the-art genetic sequencing technologies to ensure accurate and reliable results. This test is crucial for individuals displaying symptoms of HOA1 or those with a family history of the condition, as early diagnosis can significantly improve the management of the disease and the quality of life of the affected individuals.
